The VALID Act (S. 2209 and H.R. 4128), currently before Congress, provides an opportunity to set a clear, modernized regulatory framework to ensure that any test, no matter where it is developed ...

DeGette and Bucshon acknowledged that congressional inaction has left the FDA with few choices, but called again for passage of the Verifying Accurate, Leading-edge IVCT Development (VALID) Act, which ...

The VALID Act proposed dramatic oversight modifications that would have been disruptive to clinical testing laboratories and harmful to patients throughout the U.S. “AMP members have worked ...

Sen. Mike Lee, R-Utah, discusses how the VALID Act would prevent the TSA from accepting the CBP One app and addresses illegal aliens traveling within the U.S. without valid identification.

For much of 2022, the VALID Act seemed on track for passage — and then, in the final weeks of the year, legislators backed away. The VALID Act, which had bipartisan support, had been developed ...

It was with this goal in mind that a bipartisan draft version of the Verifying Accurate, Leading-edge, IVCT Development (VALID) Act was first released in 2018 by Representatives Larry Bucshon ...

Sens. Mike Lee, R-Utah, and Rick Scott, R-Fla., are pushing their VALID Act as an amendment, which would stop migrants from being able to use the Customs and Border Protection (CBP) app as an ...

To protect patients and give test developers a clearer regulatory environment, Congress should pass bipartisan legislation on diagnostics called the VALID Act that it has been discussing since 2018.

L. 113-93; H.R. 2369, the Verifying Accurate Leading-edge IVCT Development (VALID) Act, and the Fiscal Year 2024 Agriculture/FDA Appropriations bill, provisions relating to FDA oversight of laboratory ...

A conspicuous omission from the omnibus was the Verifying Accurate, Leading-edge IVCT Development (VALID) Act for FDA regulation of lab-developed tests (LDTs), an omission that drew both praise and ...